Beigene (06160) issued a total of 0.7363 million shares due to restricted stock units being granted.
Beigene (06160) announced that on June 30, 2024, due to restricted shares granted under the equity plan...
BeiGene Ltd Announces New Stock Grants
Beigene (06160.HK): Granted a total of 1760 American depositary share warrants and 56,600 restricted share units of American depositary shares.
Beigene (06160.HK) announced on July 3, that on June 28, 2024, the board of directors' compensation committee granted options to purchase a total of 1,760 American depositary shares and restricted stock units involving a total of 56,609 American depositary shares to 112 grantees in accordance with the terms of the 2016 equity incentive plan.
BeiGene plans to issue approximately 736,300 shares based on the stock plan.
Beigene (06160) announced that on June 30, 2024, the company issued a total of approximately 736,300 shares in accordance with the stock plan awarded to participants (excluding directors of the issuer) as stock awards or options.
Beigene (06160.HK) received 62.44 million shares due to restricted share unit attribution.
Beigene (06160.HK) announced on July 2 that 624,400 ordinary shares will be issued on June 30, 2024, due to the attribution of restricted share units granted under the equity plan (excluding company directors).
Asian Equities Traded in the US as American Depositary Receipts Open Week on Flat Note
Asian equities traded in the US as American depositary receipts started the week flat Monday morning, nudging 0.005% higher to 1,959.42 on the S&P Asia 50 ADR Index. From North Asia, the gainers were
Moderna And Walgreens Boots Alliance Were Among The 10 Biggest Large Cap Losers Last Week (June 23 - June 29): Are These In Your Portfolio?
These ten large-cap stocks were the worst performers in the last week. Are they in your portfolio?Walgreens Boots Alliance, Inc. (NASDAQ:WBA) shares tumbled 24.12% after the company reported mixed Q3
Beigene Insider Sold Shares Worth $445,070, According to a Recent SEC Filing
John Oyler, Director, Chief Executive Officer, on June 24, 2024, sold 2,789 shares in Beigene (BGNE) for $445,070. Following the Form 4 filing with the SEC, Oyler has control over a total of 47,949,87
Chinese Equity Market Shows Momentum to Return Cash to Shareholders
0910 GMT - The Chinese equity market's momentum to return cash to shareholders looks promising, Goldman Sachs analysts say in a research note. The strong policy push by regulators could further encour
Beigene issued a total of 5.213 million shares due to the restricted stock units being vested.
Beigene (06160) announced that a total of 5.213 million shares of common stock were issued on June 22, 2024 due to the attribution of restricted share units granted under the equity plan.
Beigene (06160.HK) obtained 5.213 million shares of restricted stock units.
Beigene (06160.HK) announced on June 24th that 5.1087 million ordinary shares were issued due to the attribution of restricted share units granted under the equity plan (excluding the company's directors) on June 22, 2024. On the same day, 104.4 thousand ordinary shares were issued due to the attribution of restricted share units granted to the company's directors under the equity plan.
Insider Sale: CFO Julia Wang Sells Shares of BeiGene Ltd (BGNE)
Beigene Insider Sold Shares Worth $368,162, According to a Recent SEC Filing
Lai Wang, Global Head of R&D, on June 17, 2024, sold 2,341 shares in Beigene (BGNE) for $368,162. Following the Form 4 filing with the SEC, Wang has control over a total of 1,796,717 shares of the com
Beigene issued approximately 1.6867 million shares of restricted stock units due to vesting of ownership.
Beigene (06160) announced that on June 17, 2024, approximately 1.6867 million shares were issued due to the attribution of restricted stock units granted under the equity plan (except for company directors).
Beigene (06160.HK) received 1,686,700 restricted stock units.
Beigene (06160.HK) issued 1.6867 million common shares on June 17, 2024, due to the ownership of restricted share units granted under the equity incentive plan (excluding company directors).
Beigene (06160) issued approximately 1.6867 million shares due to restricted share units being awarded to the beneficiary.
Beigene (06160) announced on June 17, 2024 that approximately 1.6867 million shares were issued due to the allocation of restricted share units under the equity incentive plan, excluding company directors.
Beigene (06160) issued approximately 7.1742 million shares due to the allocation of restricted share units under the equity plan.
Beigene (06160) announced that a total of approximately 7.1742 million shares were issued on June 15th and 16th, 2024 due to the attribution of restricted share units granted under the equity incentive plan.
BeiGene Says New Phase 3 Brukinsa Data Show 'Promising' Efficacy in Leukemia, Lymphoma
BeiGene (BGNE) said Friday that preliminary data from a phase 3 study of Brukinsa in combination with venetoclax to treat patients with chronic lymphocytic leukemia and/or small lymphocytic lymphoma s
Express News | Beigene: Safety Profile Was Consistent With Results of Prior Brukinsa Studies
Express News | Beigene: Preliminary Data Suggest Promising Efficacy and Tolerability